Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T ‐cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
British Journal of Haematology, EarlyView.
Source: British Journal of Haematology - Category: Hematology Authors: Jonathan Canaani
,
Myriam Labopin
,
Xiao J. Huang
,
Fabio Ciceri
,
Maria T. Van Lint
,
Benedetto Bruno
,
Stella Santarone
,
Jos é L. Diez‐Martin
,
Didier Blaise
,
Patrizia Chiusolo
,
Depei Wu
,
Mohamad Mohty
,
Arnon Nagler Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Transplants | UK Health